An Evaluation of the Knowledge and Utilization of the Essential Medicines List among Health Professionals in Six Tertiary Institutions in Nigeria.
Rattachement africain : Nigéria, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: The introduction and operationalization of the Essential Medicines (EM) concept remains a major achievement of the WHO. This study assessed the current knowledge, utilization, and perception of the Essential Medicines programme in Nigeria. METHODS: This was a cross-sectional study conducted across six tertiary health institutions in Southern Nigeria from January to July 2018. A total of 750 semi-structured questionnaires were administered to doctors, pharmacists, and nurses. The information sought included the demographic characteristics of respondents, knowledge of definition of the essential medicines concept, date of launch at the national level, current edition, current use, the advantages and disadvantages of the EM List (EML). The data were analyzed qualitatively and presented descriptively as means (SD) and percentage frequencies. RESULTS: A total of 748 respondents (487 doctors, 208 nurses, and 53 pharmacists) participated in the study. Healthcare professionals' (HCP) knowledge of the EM concept and list was poor (15%), as determined by their ability to define or describe the concept of the EML, with less than 3% of respondents aware of the current edition of the EML in use in Nigeria. Less than 20% of all respondents used the EML during their internship, with nurses using it the least and only 8% using it during their first year of practice. Over 70% of respondents could not identify notable advantages of the EML and only 14.6% agreed that the program had been successful in Nigeria. CONCLUSION: The initial global momentum following the introduction of the EM program appears to have declined with the new generation of HCPs, likely due to lack of educational reinforcement. This negatively impacts the drug use scenario within our healthcare system.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
Où se fait cette recherche
-
University of Benin Teaching Hospital Clinical Pharmacology and Therapeutics Unit Benin City, Nigéria (code pays fourni par la source)Établissement de santé
-
University of Benin Nigéria (code pays fourni par la source)Université ou école supérieure
-
Delta State University Department of Pharmacology and Therapeutics Nigéria (code pays fourni par la source)Université ou école supérieure
-
Delta State University pays non établi dans la noticeUniversité ou école supérieure
-
Irrua Specialist Teaching Hospital Nigéria (code pays fourni par la source)Établissement de santé
-
Federal Medical Centre Nigéria (code pays fourni par la source)Établissement de santé
-
Nnamdi Azikiwe University Teaching Hospital Department of Medicine Nnewi, Nigéria (code pays fourni par la source)Établissement de santé
-
Federal Neuro Psychiatric Hospital Nigéria (code pays fourni par la source)Établissement de santé
-
Irrua Specialist Hospital Department of Medicine Nigéria (pays nommé en fin d’affiliation)Établissement de santé
-
Department of Medicine Nigéria (pays nommé en fin d’affiliation)Institution
-
Federal Neuropsychiatric Hospital Benin City, Nigéria (pays nommé en fin d’affiliation)Établissement de santé
Clinical Pharmacology and Therapeutics Unit — University of Benin Teaching Hospital (Benin City, Nigéria), University of Benin (Nigéria) et Department of Pharmacology and Therapeutics — Delta State University (Nigéria), avec 8 autres affiliations. Pays d’affiliation : Nigéria.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.